Why Cannabis Companies Are Turning to eQMS

The cannabis industry in North America has grown up fast. What started as a patchwork of state-level experiments has become a multi-billion-dollar sector operating under real regulatory scrutiny. As this scrutiny intensifies, cannabis operators are faced with the fact that the informal quality systems that got them to this point won’t be able to carry them forward. Spreadsheets, shared folders, and paper-based SOPs were never designed for a regulated industry at scale, and the compliance environment cannabis companies now operate in makes that gap increasingly hard to ignore.

The shift toward electronic Quality Management Systems (eQMS) is accelerating across the cannabis space, and the drivers behind it are structural, regulatory, and operational all at once.

A Regulatory Environment Built for Complexity

The core challenge for cannabis operators in North America is that there is no single rulebook. In the U.S., cannabis remains a Schedule I controlled substance under the Controlled Substances Act, yet 38 states, the District of Columbia, and several territories have legalized medical use — most with adult-use frameworks layered on top. For a multi-state operator (MSO) expanding across Colorado, New York, and California, that means navigating three distinct regulatory regimes simultaneously, each with its own testing thresholds, labeling standards, packaging rules, and track-and-trace mandates.

California, for instance, requires testing against six specific microbial pathogens including four Aspergillus species, while Colorado requires its own microbial testing panel and mandates HACCP plans for any cultivation facility seeking reduced batch testing frequency. Managing that kind of jurisdiction-by-jurisdiction complexity through disconnected systems is a compliance liability and can be an area for weakness for regulators to focus on during audits.

In Canada, Health Canada’s Cannabis Regulations under the Cannabis Act impose Good Production Practices requirements across all licensed producers, covering everything from batch traceability to facility compliance records, along with contamination testing. Health Canada’s enforcement record makes the stakes clear. In fiscal year 2023–2024, the regulator issued 21 non-compliant inspection reports to licensed producers, with GPP failures and inadequate document retention among the most common findings. As more and more jurisdictions adopt cannabis, documented and traceable quality systems are becoming increasingly helpful for compliance.

Federal Reform Is the Accelerant

Federally, the biggest regulatory driver of eQMS adoption in cannabis is the ongoing conversation around rescheduling cannabis from Schedule I to Schedule III in the U.S., which would bring the industry under meaningful FDA oversight for the first time. That means current Good Manufacturing Practice (cGMP) requirements, 21 CFR Part 11 electronic records obligations, and the kind of audit readiness that life sciences manufacturers have been building toward for decades.

Cannabis companies operating on informal quality infrastructure today will have to significantly invest in more compliant systems to meet regulatory expectations. The operators building structured quality systems now are hedging intelligently against a directional regulatory future, based on current state regulations. The FDA has already been issuing warning letters to CBD and delta-8 THC product manufacturers, signaling that enforcement interest in cannabis-adjacent products is active and growing.

Standards Are Filling the Gap

In the absence of a unified federal framework and outside of state regulations, voluntary standards have also emerged as a practical baseline for cannabis operations. ASTM International’s standards D8556-24 and D8557-24 provide GMP and QMS guidelines written specifically for cannabis operations, and these are increasingly referenced as benchmarks for quality system adequacy. ISO/IEC 17025:2017 has similarly become standard for cannabis testing laboratories seeking accreditation. Companies that have aligned operations to these frameworks find that implementing an eQMS is a natural digitization of what good quality management already looks like on paper.

Operational Pressure: Recalls, Lab Inconsistencies, and Scale

Beyond regulation, cannabis operators are hitting the same operational walls that pushed pharma and food manufacturers toward QMS adoption years ago. Managing quality events at scale and at multiple sites through disconnected systems and manual records is a challenge for manual operations.

Lab testing inconsistency is another pressure point. Inconsistent methodologies across third-party labs and out-of-specification (OOS) results that lack documented investigation chains are compliance failures that can not only have detrimental impact but also get caught by auditors. Efficiently tackling these issues require structured workflows, linked batch records, and an unbroken chain of documentation from cultivation to product release.

Where ACE eQMS Fits In

Helping companies navigate regulatory pitfalls is precisely the environment ACE (Adaptive Compliance Engine) was built for. ACE brings the compliance infrastructure cannabis companies need right now, without the implementation burden that typically slows regulated industry software adoption.

ACE Essentials comes pre-validated with 25 ready-to-use workflows for quality events and document management in a package that is 21 CFR Part 11 compliant out of the box. For startup cannabis operators who need to demonstrate quality system adequacy to a state regulator or prospective client, this turnkey readiness is an effective way to get start building their quality management system.

For multi-site and larger operations with more complexity, ACE Enterprise delivers configurable automated workflows, end-to-end inspection management, centralized document control, advanced analytics dashboards, and built-in AI assistance all within a single platform accessible across locations.

What also sets ACE apart is the expertise behind it. PSC Software’s team includes quality professionals, regulatory experts, and validation specialists who have implemented FDA, GxP, and ISO frameworks firsthand and that knowledge is built directly into the platform’s design. For a cannabis industry navigating regulations that are still being written, having a platform backed by that depth of regulatory experience can help bring confidence and market awareness.

The companies that build audit-ready quality infrastructure before federal oversight arrives will be the ones positioned to scale when it does. ACE gives cannabis operators a path to get there without starting from scratch when federal regulations are formalized.

Interested in learning how ACE can support your cannabis quality program? Book a demo with PSC Software.